The potential risk factors leading to peptic ulcer formation in autoimmune disease patients receiving corticosteroid treatment

Alimentary Pharmacology and Therapeutics

Volumn 16, Issue 7, 2002, Pages 1241-1248

  Luo, J C ^a   Chang, F Y ^a   Lin, H Y ^a   Lu, R H ^a   Lu, C L ^a   Chen, C Y ^a   Lee, S D ^a  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; CYCLOOXYGENASE 2 INHIBITOR; HISTAMINE H2 RECEPTOR ANTAGONIST; METHYLPREDNISOLONE; NONSTEROID ANTIINFLAMMATORY AGENT; PREDNISOLONE; PROTON PUMP INHIBITOR; GLUCOCORTICOID; PROSTAGLANDIN SYNTHASE INHIBITOR;

ADULT; AGE; AGED; ARTICLE; AUTOIMMUNE DISEASE; BACTERIAL COLONIZATION; CONTROLLED STUDY; DUODENUM ULCER; FEMALE; GRAM NEGATIVE INFECTION; HELICOBACTER PYLORI; HUMAN; IMMUNE DEFICIENCY; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SMOKING; STOMACH ULCER; CHEMICALLY INDUCED DISORDER; DRUG COMBINATION; HELICOBACTER INFECTION; MIDDLE AGED; STATISTICAL MODEL;

ADULT; AGE FACTORS; AGED; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; AUTOIMMUNE DISEASES; CYCLOOXYGENASE INHIBITORS; DRUG THERAPY, COMBINATION; DUODENAL ULCER; FEMALE; GLUCOCORTICOIDS, SYNTHETIC; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMAN; LOGISTIC MODELS; MALE; MIDDLE AGE; RISK FACTORS; SMOKING; STOMACH ULCER; SUPPORT, NON-U.S. GOV'T; GLUCOCORTICOIDS; HUMANS; MIDDLE AGED;

EID: 0036024195     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2036.2002.01279.x     Document Type: Article

References (48)

1. Mechanisms of antiinflammatory action and of immunosuppression by glucocorticoids: Negative interference of activated glucocorticoid receptor with transcription factors
2. Multiple mechanisms mediate antipyretic action of glucocorticoids
3. An alternate mechanism of glucocorticoid anti-proliferative effect: Promotion of a Th2 cytokine-secreting profile
4. Histopathology of steroid-induced ulcer
5. Nonsteroidal anti-inflammatory drug-associated upper gastrointestinal lesions in rheumatoid arthritis patients
6. Influence of prednisolone on gastric alkaline response in rat stomach. A possible explanation for steroid-induced gastric lesion
7. Glucocorticoid-induced gastric mucosal damage: Inhibition of leukotriene, but not prostaglandin biosynthesis
8. Healed experimental gastric ulcer in the rat: Re-ulceration resulting from cortisone administration
9. Adrenal corticosteroids cause gastric cell hyperplasia
10. Effect of cortisol on mucoprotein secretion by gastric antrum of dogs: Pathogenesis of steroid ulcers
11. The effect of adrenocorticotropic hormone upon uropepsin excretion
12. Gastrointestinal toxicity of nonsteroidal anti-inflammatory drugs
13. No association of adrenocorticosteroid therapy and peptic ulcer
14. Association of adrenocorticosteroid therapy and peptic ulcer disease
15. Corticosteroid use and peptic ulcer disease: Role of nonsteroidal anti-inflammatory drugs
16. Peptic ulcer and its complications
17. Alcohol drinking and cigarette smoking: A 'partner' for gastric ulceration
18. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus
19. The 1982 revised criteria for the classification of systemic lupus erythematosus
20. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis
21. Preliminary criteria for the classification of systemic sclerosis
22. Results of a prospective concerted action supported by the European community. Preliminary criteria for the classification of Sjogren's syndrome
23. Do cyclooxygenase-2 inhibitors provide benefits similar to those of traditional non-steroidal anti-inflammatory drugs, with less gastrointestinal toxicity?
24. Release and action of epidermal growth factor on gastric secretion in humans
25. Weak association between subjective symptoms of and objective testing for dry eyes and dry mouth: Results from a population based study
26. Workshop on diagnostic criteria for Sjogren's syndrome. I. Questionnaires for dry eye and dry mouth. II. Manual of methods and procedures
27. Chronic xerostomia increases esophageal acid exposure and is associated with esophageal injury
28. Epidermal growth factor in gastric ulcer healing by Nocloprost, a stable prostaglandin E2 derivative
29. Omeprazole compared with misoprostol for ulcers associated with non-steroidal anti-inflammatory drugs
30. Diagnosis of Helicobacter pylori infection
31. A randomized trial comparing the effect of rofecoxib, a cyclooxygenase 2-specific inhibitor, with that of ibuprofen on the gastroduodenal mucosa of patients with osteoarthritis
32. Reduced incidence of gastroduodenal ulcers with celecoxib, a novel cyclooxygenase-2 inhibitor, compared to Naproxen in patients with arthritis
33. Helicobacter pylori induced interleukin-8 expression in gastric epithelial cells is associated with CagA positive phenotype
34. Role of cytokines in pathogenesis of Helicobacter pylori-induced mucosal damage
35. Molecular inflammation
36. Local cytokine response in Helicobacter pylori-infected subjects
37. T helper 1 effector cells specific for Helicobacter pylori in the gastric antrum of patients with peptic ulcer disease
38. Helicobacter pylori and non-steroid anti-inflammatory drugs
39. Helicobacter pylori up-regulates cyclooxygenase-2 mRNA expression and prostaglandin E2 synthesis in MKN 28 gastric mucosal cells in vitro
40. Localization of cyclooxygenase 1 and cyclooxygenase 2 in Helicobacter pylori related gastritis and gastric ulcer tissue in humans
41. Glucocorticoid modulation of human monocyte/macrophage function: Control of TNF-α secretion
42. Interaction between Helicobacter pylori and non-steroidal anti-inflammatory drugs in peptic ulcer bleeding
43. Helicobacter pylori infection is a protective factor for bleeding gastric ulcers but not for bleeding duodenal ulcer in NSAID users
44. Factors influencing gastroduodenal mucosal prostaglandin concentration: Role of smoking and aging
45. Increased production of oxygen free radicals in cigarette smokers
46. Cigarette smoke increases apoptosis in the gastric mucosa: Role of epidermal growth factor
47. Nonsteroidal anti-inflammatory drugs use and increased risk for peptic ulcer disease in elderly persons
48. Peptic ulcer: The many proteinases of aggression